December 27, 2021
The Ministry of Health, Labor and Welfare (MHLW) has withdrawn the sakigake fast-track designation for GlaxoSmithKline’s immuno-oncology therapy M7824 following the termination of the program. The MHLW reported the withdrawal to the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Pharmaceutical...read more